Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ingersoll Rand | IR | Jan 17, 2025 | 91.88 | +1.25 |
Ingevity | NGVT | Jan 17, 2025 | 47.20 | +1.59 |
Ingles Markets A | IMKTA | Jan 17, 2025 | 63.07 | -1.91 |
Ingram Micro Holding Corp | INGM | Jan 17, 2025 | 21.85 | 0.00 |
Ingredion | INGR | Jan 17, 2025 | 135.11 | +0.58 |
Inhibikase Therapeutics | IKT | Jan 17, 2025 | 2.72 | -1.45 |
Inhibrx Biosciences | INBX | Jan 17, 2025 | 13.49 | -0.37 |
INLIF | INLF | Jan 17, 2025 | 5.37 | 0.00 |
InMed Pharmaceuticals | INM | Jan 17, 2025 | 4.95 | +10.00 |
InMode | INMD | Jan 17, 2025 | 16.79 | +1.33 |
INmune Bio | INMB | Jan 17, 2025 | 6.45 | -4.02 |
Innate Pharma ADR | IPHA | Jan 17, 2025 | 1.69 | +1.20 |
Inno Holdings | INHD | Jan 17, 2025 | 5.14 | -0.19 |
Innodata | INOD | Jan 17, 2025 | 36.78 | -0.84 |
Innospec | IOSP | Jan 17, 2025 | 114.47 | +1.39 |
InnovAge | INNV | Jan 17, 2025 | 3.57 | -2.46 |
Innovate | VATE | Jan 17, 2025 | 5.11 | +4.71 |
Innovation Beverage Group | IBG | Jan 17, 2025 | 0.94 | -4.29 |
Innovative Eyewear | LUCY | Jan 17, 2025 | 5.89 | -0.17 |
Innovative Industrial Properties | IIPR | Jan 17, 2025 | 68.11 | +1.75 |
Innovative Industrial Properties A Pref | IIPR-A | Jan 17, 2025 | 25.17 | +0.12 |
Innovative Solutions and Support | ISSC | Jan 17, 2025 | 10.29 | +1.18 |
Innovex International | INVX | Jan 17, 2025 | 17.29 | +1.29 |
Innovid | CTV | Jan 17, 2025 | 3.08 | 0.00 |
Innoviva | INVA | Jan 17, 2025 | 18.58 | +0.70 |
Innoviz Technologies | INVZ | Jan 17, 2025 | 1.62 | -5.81 |
InnSuites Hospitality | IHT | Jan 17, 2025 | 2.53 | +1.20 |
Innventure | INV | Jan 17, 2025 | 12.60 | -2.48 |
Inogen | INGN | Jan 17, 2025 | 10.47 | -0.48 |
Inotiv | NOTV | Jan 17, 2025 | 4.27 | -1.16 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.